Literature DB >> 28802094

Oncocytic variant of medullary thyroid carcinoma; a rare tumor with numerous diagnostic mimics by fine needle aspiration.

Sharon B Sams1, Kenneth D Tompkins2, Sarah Mayson2, Christopher D Raeburn3, Sanjana Mehrotra1.   

Abstract

Oncocytic variant of medullary thyroid carcinoma is rare form of thyroid carcinoma that is easily misdiagnosed on fine needle aspiration specimens due to it is low incidence and cytomorphologic overlap with other more common Hurtle cell lesions. A correct initial diagnosis by fine needle aspiration is imperative as the clinical treatment for medullary carcinoma differs significantly from the mimickers. We present a case of this rare variant tumor that on initial fine needle aspiration was described as a Hurthle cell lesion and was subsequently correctly classified on the resection specimen. In this brief review, we describe the cytomorphologic features of medullary carcinoma, oncocytic variant of medullary carcinoma and it is most common mimickers, and we discuss the ancillary studies required to confirm the diagnosis. This case highlights the importance of a complete clinical history and radiologic correlation, which in conjunction with a careful attention to the cytologic features of the fine needle aspiration sample, should in most cases ensure a correct initial diagnosis.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  fine needle aspiration; hurthle cell neoplasm; medullary thyroid carcinoma; oncocytic

Mesh:

Year:  2017        PMID: 28802094     DOI: 10.1002/dc.23790

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

1.  Multiple Auer Rods in Fine-Needle Aspiration Smears of Medullary Thyroid Carcinoma: An Unusual Finding.

Authors:  Maryam Mohammadnia Avval; Perikala Vijayananda Kumar; Fereydoon Dehghani
Journal:  Int Med Case Rep J       Date:  2020-03-10

Review 2.  Challenges in Cytology Specimens With Hürthle Cells.

Authors:  Eleni Thodou; Sule Canberk; Fernando Schmitt
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-25       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.